SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 136 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,077 | +16.6% | 63,784 | -4.5% | 0.01% | +20.0% |
| Q1 2024 | $8,645 | +178.3% | 66,780 | +107.3% | 0.01% | +150.0% |
| Q4 2023 | $3,106 | +8.8% | 32,219 | +36.8% | 0.00% | 0.0% |
| Q3 2023 | $2,855 | -30.4% | 23,559 | -34.3% | 0.00% | -33.3% |
| Q2 2023 | $4,103 | -99.7% | 35,835 | +117.9% | 0.00% | +200.0% |
| Q4 2021 | $1,480,000 | +1.1% | 16,443 | -12.1% | 0.00% | 0.0% |
| Q3 2021 | $1,464,000 | +0.2% | 18,711 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $1,461,000 | – | 18,801 | -43.6% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 33,355 | +11401.7% | 0.00% | – |
| Q3 2020 | $40,000 | +185.7% | 290 | +222.2% | 0.00% | – |
| Q2 2020 | $14,000 | +75.0% | 90 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -99.8% | 90 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $3,638,000 | +32.4% | 28,197 | +55.9% | 0.01% | 0.0% |
| Q2 2019 | $2,748,000 | +151.4% | 18,090 | +97.1% | 0.01% | +166.7% |
| Q1 2019 | $1,093,000 | +62.2% | 9,177 | +48.5% | 0.00% | +50.0% |
| Q4 2018 | $674,000 | -58.6% | 6,180 | -38.7% | 0.00% | -60.0% |
| Q3 2018 | $1,628,000 | -27.2% | 10,085 | -40.4% | 0.01% | -44.4% |
| Q2 2018 | $2,236,000 | +73.7% | 16,920 | -2.6% | 0.01% | -84.2% |
| Q1 2018 | $1,287,000 | +27.2% | 17,379 | -4.5% | 0.06% | +29.5% |
| Q4 2017 | $1,012,000 | -51.9% | 18,199 | -60.8% | 0.04% | -48.8% |
| Q3 2017 | $2,104,000 | +211.7% | 46,396 | +131.5% | 0.09% | +196.6% |
| Q2 2017 | $675,000 | -52.0% | 20,040 | -57.8% | 0.03% | -52.5% |
| Q1 2017 | $1,405,000 | +114.8% | 47,481 | +38.4% | 0.06% | +38.6% |
| Q2 2016 | $654,000 | +11.6% | 34,308 | +14.2% | 0.04% | -6.4% |
| Q1 2016 | $586,000 | -41.0% | 30,049 | +16.6% | 0.05% | -39.7% |
| Q4 2015 | $994,000 | +146.7% | 25,776 | +105.2% | 0.08% | +160.0% |
| Q3 2015 | $403,000 | +47.6% | 12,561 | +39.6% | 0.03% | +30.4% |
| Q2 2015 | $273,000 | +11.0% | 8,998 | -51.6% | 0.02% | -20.7% |
| Q1 2015 | $246,000 | -41.4% | 18,578 | -36.0% | 0.03% | -43.1% |
| Q4 2014 | $420,000 | – | 29,031 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |